Med ePad Raises £50K from North West Fund for Biomedical
Med ePad, a Liverpool Science Park (UK)-based startup that has developed an interactive touch screen mobile internet device for healthcare service providers, has raised £50k from the £25m North West Fund for Biomedical.
The company intends to use the funds to develop initial apps and run a number of real trials with healthcare services in both primary and secondary care.
Med ePad’s 7-inch tablet has been designed to come loaded with condition specific apps created in conjunction with NHS healthcare professionals. It aims to improve the efficiency of treatment and empower patients to better manage their self-care.
Functions include the ability to record medication regimes and daily living patterns, send appointment reminders, conduct online consultations and access specific information relating to a particular condition, and where appropriate in the language of the patients choice.
The company was founded by CTO Rob Connell.
Run by early-stage venture capital firm SPARK Impact, the North West Fund for Biomedical is a sub-fund of the £185m North West Fund, which is financed by the ERDF and the EIB.